The transition to first-in-human studies is one of the most significant and challenging stages in the drug development lifecycle. Achieving this milestone requires careful planning, cross-functional collaboration, and a strategic framework that connects scientific advancement with operational readiness.
In this webinar, specialists from inSeption Group discuss effective approaches for preparing for early clinical development and IND submission. The session outlines practical methods for identifying potential obstacles early, coordinating stakeholders across functions, and establishing the operational foundation necessary to move efficiently and compliantly toward first patient enrollment.
Viewers will gain a holistic understanding of the first-in-human journey and learn how decisions made during early development can shape future clinical success. The presentation examines the interplay between scientific, regulatory, manufacturing, and operational activities during this critical phase, while also addressing common pitfalls that can impact timelines and study execution. Watch the full webinar below to discover how proactive planning, experienced guidance, and integrated partnerships can help protect your program and accelerate clinical advancement.
